Porsolt Increases Its Drug Discovery Service Capabilities With...
LAVAL, France, Sept. 4, 2019 /PRNewswire-AsiaNet/ -- Porsolt SAS, a long established preclinical screening, efficacy, and safety CRO, has completed a significant expansion of its research facility, adding a further 5,500 sq.ft. of experimental space. The expansion integrates Porsolt's new areas ...
Authors: LATEST ASIANET NEWS RELEASES